US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CytomX Therapeutics

2.64

+0.240010.00%

Volume:3.41M

Turnover:8.89M

Market Cap:415.92M

PE:5.44

High:2.71

Open:2.46

Low:2.43

Close:2.40

Loading ...

Overview Company News Filings

FDA Accepts J&J's Filing for Autoimmune Disease Drug Nipocalimab

VIR Stock Up on Early Safety & Efficacy Data on Two Cancer Candidates

FDA Accepts Agios' sNDA for Pyrukynd in Thalassemia

FDA Clears PCRX's New Iovera Smart Tip for Expanded Use in Pain Relief

HOTH Stock Soars as Skin Toxicity Study in Cancer Patients Meets Goal

All You Need to Know About CytomX Therapeutics (CTMX) Rating Upgrade to Strong Buy

CytomX Therapeutics price target lowered to $5 from $8 at Wedbush

Wedbush Adjusts CytomX Therapeutics' PT to $5 From $8, Keeps Outperform Rating

MT Newswires Live

CytomX Therapeutics Inc : Wedbush Cuts Target Price to $5 From $8

THOMSON REUTERS

Piper Sandler Sticks to Its Buy Rating for CytomX Therapeutics (CTMX)

H.C. Wainwright Keeps Their Hold Rating on CytomX Therapeutics (CTMX)

CytomX Therapeutics to Cut 40% of Workforce

CytomX Therapeutics says focus on development of CRC treatment CX-2051 in FY25

CytomX Therapeutics Inc -CytomX Will Reduce Organizational Headcount by Approximately 40 Percent

THOMSON REUTERS

CytomX Therapeutics Inc - Initial Phase 1a Data for Cx-2051 Expected in H1 2025

THOMSON REUTERS

CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update

THOMSON REUTERS

CytomX Therapeutics Inc -Revised Focus and Associated Cost and Headcount Reductions Expected to Extend Cash Runway Into Q2 of 2026

THOMSON REUTERS

KOD Stock Rallies 271% in 6 Months on Eye Disease Program Updates

Here's Why Arcutis Stock More Than Doubled in Market Value in One Year

MESO Stock Surges 80% in a Month After FDA Approval of GVHD Drug

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CTMX/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CTMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTMX\",,,,,undefined,":{"symbol":"CTMX","market":"US","secType":"STK","nameCN":"CytomX Therapeutics","latestPrice":2.64,"timestamp":1749240000000,"preClose":2.4,"halted":0,"volume":3414100,"delay":0,"floatShares":152000000,"shares":157544369,"eps":0.485379,"marketStatus":"Pre-Mkt","change":0.24,"latestTime":"06-09 05:04:51 EDT","open":2.46,"high":2.707,"low":2.4301,"amount":8892761.91983,"amplitude":0.115375,"askPrice":2.7,"askSize":500,"bidPrice":2.24,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.485379,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749475800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1444276800000,"exchange":"NASDAQ","adjPreClose":2.64,"postHourTrading":{"tag":"盘后","latestPrice":2.65,"preClose":2.64,"latestTime":"18:59 EDT","volume":4389,"amount":11558.1348,"timestamp":1749250765806},"volumeRatio":1.326136433621214,"impliedVol":0.6194,"impliedVolPercentile":0.2932},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTMX\",,,,,undefined,":{"symbol":"CTMX","floatShares":152000000,"roa":"15.87%","roe":"-139.27%","lyrEps":0.377419,"volumeRatio":1.326136433621214,"shares":157544369,"dividePrice":0,"high":2.707,"amplitude":0.115375,"preClose":2.4,"low":2.4301,"week52Low":0.4,"pbRate":"16.60","psRate":"2.82","week52High":2.82,"institutionHeld":0,"latestPrice":2.64,"committee":-0.666667,"eps":0.485379,"divideRate":0,"volume":3414100,"delay":0,"ttmEps":0.485379,"open":2.46,"prevYearClose":1.03,"prevWeekClose":2.64,"prevMonthClose":2.65,"prevQuarterClose":0.6358,"fiveDayClose":2.65,"twentyDayClose":1.09,"sixtyDayClose":0.5988},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTMX\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2502468898","title":"FDA Accepts J&J's Filing for Autoimmune Disease Drug Nipocalimab","url":"https://stock-news.laohu8.com/highlight/detail?id=2502468898","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502468898?lang=en_us&edition=fundamental","pubTime":"2025-01-10 21:24","pubTimestamp":1736515440,"startTime":"0","endTime":"0","summary":"Johnson & Johnson JNJ announced that the FDA has accepted its regulatory filing seeking the FDA’s approval for nipocalimab, its investigational neonatal Fc receptor  blocker, in generalized myasthenia gravis  indication.The filing has been granted priority review by the FDA, bringing down the review period by four months. We expect a final decision in the third quarter of 2025.The FDA filing is supported by data from the phase III Vivacity-MG3 study, which evaluated nipocalimab in adults with gMG, including those with anti-AChR, anti-MuSK and anti-LRP4 positive antibodies. Data from the study showed that patients who received nipocalimab plus standard of care achieved sustained disease controlover 24 weeks compared with those who received placebo plus SOC. A similar regulatory filing for the drug is under review by the EMA, also supported by data from this study.Per J&J, the above results make Vivacity-MG3 the first and only study to achieve sustained disease control in gMG patients wi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-accepts-j-js-filing-132400420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4533","LU1066051498.USD","IE00B4R5TH58.HKD","ARGX","LU0320765992.SGD","LU1066051811.HKD","LU0320765646.SGD","LU0058720904.USD","LU1280957306.USD","LU0122379950.USD","BK4550","LU0345770993.USD","LU0912757837.SGD","LU1732800096.USD","IE0002270589.USD","LU0345770308.USD","LU1057294990.SGD","LU1935042991.SGD","IE00BJJMRZ35.SGD","IE0034235303.USD","BK4213","LU0792757196.USD","BK4505","LU0109394709.USD","LU0345769128.USD","SG9999001440.SGD","CSTL","SG9999002224.SGD","IE00B2B36J28.USD","CTMX","LU1066051225.USD","LU1221951046.USD","LU1674673691.USD","SOC","LU1894683264.USD","LU1162221912.USD","LU0889565916.HKD","IE0009355771.USD","IE00BVYPNV92.GBP","LU0114720955.EUR","LU0098860793.USD","IE00B1BXHZ80.USD","LU0234570918.USD","LU0466842654.USD","LU1032466523.USD","LU1032955483.USD","BK4139","LU1244550577.SGD","JNJ","LU1261432733.SGD"],"gpt_icon":0},{"id":"2502636025","title":"VIR Stock Up on Early Safety & Efficacy Data on Two Cancer Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2502636025","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502636025?lang=en_us&edition=fundamental","pubTime":"2025-01-10 00:42","pubTimestamp":1736440920,"startTime":"0","endTime":"0","summary":"Vir Biotechnology, Inc. VIR announced encouraging initial data from a phase I study that evaluated its investigational pipeline candidates, VIR-5818 and VIR-5500, for the treatment of various solid tumors.While VIR-5818 is designed to target a variety of HER2-expressing solid tumors, VIR-5500 is designed to target PSMA in metastatic castration-resistant prostate cancer .Initial data from the phase I study demonstrated compelling early clinical response signals for both T-cell engagers , VIR-5818 and VIR-5500, in heavily pretreated patients with various types of solid tumors.Shares of Vir Biotechnology jumped 58.2% on Jan. 8 following the announcement of the news.In the past year, shares of VIR have rallied 21.1% against the industry’s decline of 14.3%.Per the company, VIR-5818 and VIR-5500 leverage the PRO-XTEN masking technology with different TCEs targeting HER2 and PSMA, respectively. The technology is designed to allow the selective activation of TCEs in the tumor microenvironment,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vir-stock-early-safety-efficacy-164200842.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSA","BK4217","BK4588","BK4139","BK4196","CTMX","BK4568","BK4585","BK4213","VIR","CRC","BK4535","PBYI","BK4533","CSTL","LU0456854461.SGD","LU0266512127.USD","BK4084"],"gpt_icon":0},{"id":"2502043249","title":"FDA Accepts Agios' sNDA for Pyrukynd in Thalassemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2502043249","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502043249?lang=en_us&edition=fundamental","pubTime":"2025-01-09 21:14","pubTimestamp":1736428440,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals AGIO announced that the FDA has accepted its supplemental new drug application  seeking label expansion for its sole marketed drug, Pyrukynd, in thalassemia indication.A final decision is expected by Sep. 7, 2025. If approved, Pyrukynd will become the first oral therapy for use in all thalassemia subtypes. A commercial launch in this indication is expected before this year’s end.The sNDA is supported by data from two phase III studies, ENERGIZE and ENERGIZE-T, which evaluated Pyrukynd for alpha or beta-thalassemia patients who are non-transfusion-dependent and transfusion-dependent, respectively. Both studies achieved their primary and key secondary endpoints. Similar regulatory filings have been submitted by Agios in the European Union, Kingdom of Saudi Arabia and United Arab Emirates, supported by data from the two studies.Pyrukynd is currently approved by the FDA to treat adults with pyruvate kinase deficiency, a rare and debilitating blood disorder. It is the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-accepts-agios-snda-pyrukynd-131400406.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RPRX","CSTL","BK4007","CTMX","BK4196","AGIO","BK4139"],"gpt_icon":0},{"id":"2502709095","title":"FDA Clears PCRX's New Iovera Smart Tip for Expanded Use in Pain Relief","url":"https://stock-news.laohu8.com/highlight/detail?id=2502709095","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502709095?lang=en_us&edition=fundamental","pubTime":"2025-01-09 00:12","pubTimestamp":1736352720,"startTime":"0","endTime":"0","summary":"Pacira BioSciencesPCRX announced that the FDA has cleared its application to market a new Smart Tip for the iovera system designed to access the medial branch nerves to manage chronic low back pain. Please note that this hand-held medical devicewas added to Pacira’s portfolio following the acquisition of MyoScience.The iovera system is a groundbreaking, FDA-approved, drug-free treatment that alleviates pain through cryoneurolysis. This technique uses targeted cold therapy to temporarily disrupt a nerve's ability to transmit pain signals. Patients usually experience immediate pain relief after treatment, with effects lasting for several months as the nerve naturally regenerates.Per the data readout, patients treated with iovera experienced significantly greater pain reduction, with scores more than 2 points lower on the 0-10 NRS Pain scale at 180 and 360 days compared to RFA. After 360 days of treatment, iovera patients experienced statistically and clinically significant improvements i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-clears-pcrxs-iovera-smart-161200175.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0053671581.USD","HALO","CTMX","CSTL","PCRX","BK4139","BK4196","BK4007"],"gpt_icon":0},{"id":"2502706615","title":"HOTH Stock Soars as Skin Toxicity Study in Cancer Patients Meets Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2502706615","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502706615?lang=en_us&edition=fundamental","pubTime":"2025-01-08 23:41","pubTimestamp":1736350860,"startTime":"0","endTime":"0","summary":"Shares of Hoth Therapeutics HOTH skyrocketed 178.2% on Tuesday after the company announced positive interim safety and efficacy results from a mid-stage study of its lead candidate, HT-001, which is being developed to address skin toxicities linked to cancer patients undergoing treatment with EGFR inhibitors.Per the data readout from the ongoing phase IIa study, all patients treated with the candidate achieved the primary efficacy endpoint of an ARIGA score ≤1, showing significant skin toxicity improvement by the six-week mark. Hoth's proprietary ARIGA scale, developed in partnership with onco-dermatology experts, provides an accurate tool for measuring and evaluating improvements in skin toxicity.Additionally, 66% of patients treated withHT-001 reported reduced pain and itching scores, which significantly improved their quality of life. Importantly, all patients retained their full EGFR inhibitor dosage, ensuring the cancer treatment's complete therapeutic efficacy. This is a signific","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hoth-stock-soars-skin-toxicity-154100180.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CSTL","HALO","LU0053671581.USD","HOTH","BK4139","CTMX","BK4007","BK4196"],"gpt_icon":1},{"id":"2501661731","title":"All You Need to Know About CytomX Therapeutics (CTMX) Rating Upgrade to Strong Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2501661731","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501661731?lang=en_us&edition=fundamental","pubTime":"2025-01-08 01:00","pubTimestamp":1736269213,"startTime":"0","endTime":"0","summary":"Investors might want to bet on CytomX Therapeutics , as it has been recently upgraded to a Zacks Rank #1 . This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.Therefore, the Zacks rating upgrade for CytomX Therapeutics basically reflects positivity about its earnings outlook that could translate into buying pressur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/know-cytomx-therapeutics-ctmx-rating-170013743.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CTMX"],"gpt_icon":0},{"id":"2501202294","title":"CytomX Therapeutics price target lowered to $5 from $8 at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2501202294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501202294?lang=en_us&edition=fundamental","pubTime":"2025-01-07 22:06","pubTimestamp":1736258799,"startTime":"0","endTime":"0","summary":"Wedbush lowered the firm’s price target on CytomX Therapeutics (CTMX) to $5 from $8 and keeps an Outperform rating on the shares. The firm notes Cy...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cytomx-therapeutics-price-target-lowered-to-5-from-8-at-wedbush?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cytomx-therapeutics-price-target-lowered-to-5-from-8-at-wedbush?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTMX"],"gpt_icon":0},{"id":"2501732201","title":"Wedbush Adjusts CytomX Therapeutics' PT to $5 From $8, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2501732201","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501732201?lang=en_us&edition=fundamental","pubTime":"2025-01-07 21:43","pubTimestamp":1736257415,"startTime":"0","endTime":"0","summary":"CytomX Therapeutics (CTMX) has an average rating of overweight and mean price target of $4.69, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CTMX","PT"],"gpt_icon":0},{"id":"2501277725","title":"CytomX Therapeutics Inc : Wedbush Cuts Target Price to $5 From $8","url":"https://stock-news.laohu8.com/highlight/detail?id=2501277725","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501277725?lang=en_us&edition=fundamental","pubTime":"2025-01-07 19:57","pubTimestamp":1736251054,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nFWN3O31BX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTMX","BK4139"],"gpt_icon":0},{"id":"2501277952","title":"Piper Sandler Sticks to Its Buy Rating for CytomX Therapeutics (CTMX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2501277952","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501277952?lang=en_us&edition=fundamental","pubTime":"2025-01-07 19:47","pubTimestamp":1736250461,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Joseph Catanzaro maintained a Buy rating on CytomX Therapeutics (CTMX – Research Report) today and set a price target of $3.2...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-cytomx-therapeutics-ctmx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-cytomx-therapeutics-ctmx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTMX"],"gpt_icon":0},{"id":"2501613272","title":"H.C. Wainwright Keeps Their Hold Rating on CytomX Therapeutics (CTMX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2501613272","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501613272?lang=en_us&edition=fundamental","pubTime":"2025-01-07 19:28","pubTimestamp":1736249286,"startTime":"0","endTime":"0","summary":"In a report released today, Mitchell Kapoor from H.C. Wainwright reiterated a Hold rating on CytomX Therapeutics (CTMX – Research Report). The comp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-hold-rating-on-cytomx-therapeutics-ctmx-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-hold-rating-on-cytomx-therapeutics-ctmx-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTMX"],"gpt_icon":0},{"id":"2501295607","title":"CytomX Therapeutics to Cut 40% of Workforce","url":"https://stock-news.laohu8.com/highlight/detail?id=2501295607","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501295607?lang=en_us&edition=fundamental","pubTime":"2025-01-07 06:26","pubTimestamp":1736202360,"startTime":"0","endTime":"0","summary":"CytomX Therapeutics said it would reduce its organizational headcount by about 40%, primarily affecting staff in general and administrative functions.The oncology-focused biopharma company said Monday the job cuts are expected to extend its cash runway into the second quarter of 2026.CytomX expects the restructuring to cost about $5 million to $6 million. The charges will be recorded in the first quarter of this year, when the layoffs are expected to be substantially completed. The costs are related to one-time termination severance payments.The smaller workforce that remains will prioritize CX-2051, CytomX's tumor-fighting drug candidate.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CTMX"],"gpt_icon":0},{"id":"2501767267","title":"CytomX Therapeutics says focus on development of CRC treatment CX-2051 in FY25","url":"https://stock-news.laohu8.com/highlight/detail?id=2501767267","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501767267?lang=en_us&edition=fundamental","pubTime":"2025-01-07 05:15","pubTimestamp":1736198132,"startTime":"0","endTime":"0","summary":"“CytomX Therapeutics (CTMX) announced updated pipeline priorities and anticipated milestones for 2025. “Our top strategic objective for 2025 is the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cytomx-therapeutics-says-focus-on-development-of-crc-treatment-cx-2051-in-fy25?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cytomx-therapeutics-says-focus-on-development-of-crc-treatment-cx-2051-in-fy25?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0788109048.HKD","BK4213","CX","LU0266512127.USD","LU0572108347.SGD","CRC","CTMX","LU0456854461.SGD","BK4139","LU0072463663.USD","BK4011"],"gpt_icon":0},{"id":"2501677267","title":"CytomX Therapeutics Inc -CytomX Will Reduce Organizational Headcount by Approximately 40 Percent","url":"https://stock-news.laohu8.com/highlight/detail?id=2501677267","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501677267?lang=en_us&edition=fundamental","pubTime":"2025-01-07 05:05","pubTimestamp":1736197501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA3H3JZL:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTMX","BK4139"],"gpt_icon":0},{"id":"2501675682","title":"CytomX Therapeutics Inc - Initial Phase 1a Data for Cx-2051 Expected in H1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2501675682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501675682?lang=en_us&edition=fundamental","pubTime":"2025-01-07 05:05","pubTimestamp":1736197501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA3H3JZL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CTMX"],"gpt_icon":0},{"id":"2501267569","title":"CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2501267569","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501267569?lang=en_us&edition=fundamental","pubTime":"2025-01-07 05:05","pubTimestamp":1736197501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA3H3JZL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTMX","BK4139"],"gpt_icon":0},{"id":"2501267555","title":"CytomX Therapeutics Inc -Revised Focus and Associated Cost and Headcount Reductions Expected to Extend Cash Runway Into Q2 of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2501267555","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501267555?lang=en_us&edition=fundamental","pubTime":"2025-01-07 05:05","pubTimestamp":1736197501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA3H3JZL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTMX","BK4139"],"gpt_icon":0},{"id":"2501025191","title":"KOD Stock Rallies 271% in 6 Months on Eye Disease Program Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2501025191","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501025191?lang=en_us&edition=fundamental","pubTime":"2025-01-06 21:59","pubTimestamp":1736171940,"startTime":"0","endTime":"0","summary":"Shares of Kodiak Sciences KOD have skyrocketed 270.7% in the past six months fueled by updates from the developmental program of its lead investigational candidate, tarcocimab. It is a novel anti-VEGF antibody biopolymer conjugate, which is being evaluated for treating retinal vascular diseases.In late 2023, Kodiak rebooted the development program of tarcocimab following positive phase III results from the GLOW1 study, which evaluated the treatment in patients with moderately severe to severe non-proliferative diabetic retinopathy. Leveraging the GLOW1 study's success, Kodiak initiated the GLOW2 study in late 2023 to further investigate tarcocimab for diabetic retinopathy  and began dosing patients in May 2024, with enrollment expected to be completed soon. The success of the GLOW2 study is expected to serve as the basis for a single biologics license application submission for tarcocimab, seeking its approval for DR.The revival of tarcocimab in Kodiak's pipeline, after a major setback","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kod-stock-rallies-271-6-135900100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4505","BK4139","CTMX","VNDA","BK4196","CSTL","KOD"],"gpt_icon":0},{"id":"2500263831","title":"Here's Why Arcutis Stock More Than Doubled in Market Value in One Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2500263831","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500263831?lang=en_us&edition=fundamental","pubTime":"2025-01-04 02:28","pubTimestamp":1735928880,"startTime":"0","endTime":"0","summary":"Shares of small biotech Arcutis Biotherapeutics ARQT have surged nearly three times in market value in the past year.The upside has been primarily driven by the positive regulatory updates regarding the company’s efforts to expand the label of its only marketed product, Zoryve.This drug is currently approved for use in different formulations – as foam and cream – across different indications.In the past year, Arcutis’ stock has skyrocketed over 272% against the industry’s 14.1% fall.In the past 60 days, estimates for Spero Therapeutics’ 2024 loss per share have narrowed from $1.59 to $1.29. Estimates for 2025 loss per share have narrowed from $1.54 to 79 cents during the same timeframe. In the past year, Spero’s shares have lost 26.5%.SPRO’s earnings beat estimates in two of the trailing four quarters and missed the m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-arcutis-stock-more-182800155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ARQT","BK4196","BK4139","CSTL","CTMX","SPRO"],"gpt_icon":0},{"id":"2500141989","title":"MESO Stock Surges 80% in a Month After FDA Approval of GVHD Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2500141989","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500141989?lang=en_us&edition=fundamental","pubTime":"2025-01-03 23:56","pubTimestamp":1735919760,"startTime":"0","endTime":"0","summary":"Shares of Mesoblast Limited MESO have soared 80% in one month following the FDA approval of remestemcel-L as the only approved therapy for steroid-refractory acute graft versus host disease  in children aged two months and older, including adolescents and teenagers. The drug has a novel mechanism of action and will be marketed under the brand name Ryoncil in the United States.The approval gave Mesoblast its first approved product in its portfolio. Sales of the drug are expected to provide the company with a steady source of income. The company is currently gearing up to launch the product in the U.S. market.SR-aGVHD is a devastating condition that has an extremely poor prognosis. Each year in the United States, around 10,000 patients, including 1,500 children, undergo allogeneic bone marrow transplants. About 50% develop aGvHD, and nearly half of these cases are steroid-resistant.In the past six months, shares of Mesoblast have skyrocketed 202.9% against the industry’s 4.8% decline.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/meso-stock-surges-80-month-155600622.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MSB.AU","CTMX","SPRO","CSTL","MESO","BK4139","BK4196"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":5,"totalSize":124,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTMX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"CTMX","fiscalQuarterEnding":"2025/03","expectedEps":0.18,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":0.27},{"market":"US","date":"2025-03-06","symbol":"CTMX","fiscalQuarterEnding":"2024/12","expectedEps":-0.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":0.22},{"market":"US","date":"2024-11-07","symbol":"CTMX","fiscalQuarterEnding":"2024/09","expectedEps":-0.16,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2024-08-08","symbol":"CTMX","fiscalQuarterEnding":"2024/06","expectedEps":-0.07,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2024-05-08","symbol":"CTMX","fiscalQuarterEnding":"2024/03","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"post","actualEps":0.17}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTMX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.3333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":6,"updateTime":1747368000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CTMX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CTMX","date":"2025-06-06","current":9.088443,"percent":0.992635,"low":-610.657204,"twenty":-6.623429,"median":-1.975939,"eighty":1.42068,"high":17.165432,"avg":-11.616833,"sd":52.584847,"marketCap":378106485},"quantilePoints":[{"date":"2020-06-12","current":-4.815618,"twenty":-20.712849,"median":-14.355987,"eighty":-5.538565,"marketCap":365548711},{"date":"2020-06-19","current":-4.991061,"twenty":-20.67726,"median":-14.320237,"eighty":-5.498237,"marketCap":378866441},{"date":"2020-06-26","current":-4.960812,"twenty":-20.659465,"median":-14.307541,"eighty":-5.450843,"marketCap":376570281},{"date":"2020-07-02","current":-5.087857,"twenty":-20.576155,"median":-14.261373,"eighty":-5.410082,"marketCap":386214154},{"date":"2020-07-10","current":-5.15743,"twenty":-20.54514,"median":-14.219636,"eighty":-5.323504,"marketCap":391495322},{"date":"2020-07-17","current":-5.217927,"twenty":-20.527127,"median":-14.149251,"eighty":-5.258418,"marketCap":396087643},{"date":"2020-07-24","current":-4.694622,"twenty":-20.508161,"median":-14.129808,"eighty":-5.184654,"marketCap":356364070},{"date":"2020-07-31","current":-4.240889,"twenty":-20.453444,"median":-14.109343,"eighty":-5.169529,"marketCap":321921667},{"date":"2020-08-07","current":-5.620336,"twenty":-20.373286,"median":-14.106574,"eighty":-5.154405,"marketCap":351984762},{"date":"2020-08-14","current":-5.063465,"twenty":-20.352356,"median":-14.089783,"eighty":-5.154405,"marketCap":317109631},{"date":"2020-08-21","current":-5.126159,"twenty":-20.331137,"median":-14.019604,"eighty":-5.154405,"marketCap":321035970},{"date":"2020-08-28","current":-5.266299,"twenty":-20.312283,"median":-14.008481,"eighty":-5.154405,"marketCap":329812493},{"date":"2020-09-04","current":-4.838504,"twenty":-20.247683,"median":-13.96477,"eighty":-5.153195,"marketCap":303021002},{"date":"2020-09-11","current":-4.963892,"twenty":-20.22172,"median":-13.958967,"eighty":-5.109636,"marketCap":310873680},{"date":"2020-09-18","current":-5.458069,"twenty":-20.170596,"median":-13.951802,"eighty":-5.125358,"marketCap":341822472},{"date":"2020-09-25","current":-5.015523,"twenty":-20.11461,"median":-13.913989,"eighty":-5.067288,"marketCap":314107136},{"date":"2020-10-02","current":-4.772122,"twenty":-20.08008,"median":-13.899365,"eighty":-5.057355,"marketCap":298863702},{"date":"2020-10-09","current":-5.026586,"twenty":-20.064176,"median":-13.876559,"eighty":-5.053194,"marketCap":314800020},{"date":"2020-10-16","current":-5.059777,"twenty":-20.057081,"median":-13.857118,"eighty":-5.052064,"marketCap":316878670},{"date":"2020-10-23","current":-4.98602,"twenty":-20.043774,"median":-13.828188,"eighty":-5.029108,"marketCap":312259447},{"date":"2020-10-30","current":-4.882759,"twenty":-20.036656,"median":-13.801088,"eighty":-5.021444,"marketCap":305792536},{"date":"2020-11-06","current":-6.049502,"twenty":-20.01928,"median":-13.780006,"eighty":-5.018995,"marketCap":324495302},{"date":"2020-11-13","current":-6.376968,"twenty":-20.003719,"median":-13.762466,"eighty":-5.021444,"marketCap":342060574},{"date":"2020-11-20","current":-6.308028,"twenty":-19.990391,"median":-13.711175,"eighty":-5.022352,"marketCap":338362622},{"date":"2020-11-27","current":-6.394203,"twenty":-19.977759,"median":-13.596608,"eighty":-5.024373,"marketCap":342985062},{"date":"2020-12-04","current":-6.376968,"twenty":-19.969125,"median":-13.573758,"eighty":-5.026896,"marketCap":342060574},{"date":"2020-12-11","current":-6.532084,"twenty":-19.953786,"median":-13.48235,"eighty":-5.028526,"marketCap":350380967},{"date":"2020-12-18","current":-6.738904,"twenty":-19.927699,"median":-13.396874,"eighty":-5.032258,"marketCap":361474823},{"date":"2020-12-24","current":-6.394203,"twenty":-19.920158,"median":-13.309968,"eighty":-5.03608,"marketCap":342985062},{"date":"2020-12-31","current":-5.644479,"twenty":-19.913392,"median":-13.266804,"eighty":-5.039459,"marketCap":302769833},{"date":"2021-01-08","current":-6.376968,"twenty":-19.876131,"median":-13.133036,"eighty":-5.051559,"marketCap":342060574},{"date":"2021-01-15","current":-6.833697,"twenty":-19.875411,"median":-13.071715,"eighty":-5.052401,"marketCap":366559507},{"date":"2021-01-22","current":-7.50172,"twenty":-19.86922,"median":-13.049885,"eighty":-5.052401,"marketCap":402392271},{"date":"2021-01-29","current":-7.795021,"twenty":-19.846267,"median":-13.019446,"eighty":-5.053459,"marketCap":418124901},{"date":"2021-02-05","current":-9.390938,"twenty":-19.831701,"median":-12.942812,"eighty":-5.058566,"marketCap":503729902},{"date":"2021-02-12","current":-10.512244,"twenty":-19.824377,"median":-12.897211,"eighty":-5.059777,"marketCap":563876757},{"date":"2021-02-19","current":-10.418802,"twenty":-19.821989,"median":-12.77593,"eighty":-5.06199,"marketCap":558864519},{"date":"2021-02-26","current":-15.976239,"twenty":-19.809797,"median":-12.810718,"eighty":-5.063581,"marketCap":525378614},{"date":"2021-03-05","current":-15.833776,"twenty":-19.799678,"median":-12.921607,"eighty":-5.067288,"marketCap":520693709},{"date":"2021-03-12","current":-17.299112,"twenty":-19.76851,"median":-12.921607,"eighty":-5.067288,"marketCap":568881302},{"date":"2021-03-19","current":-16.831018,"twenty":-19.712796,"median":-12.921607,"eighty":-5.067288,"marketCap":553488043},{"date":"2021-03-26","current":-15.508145,"twenty":-19.620977,"median":-12.922693,"eighty":-5.068498,"marketCap":509985355},{"date":"2021-04-01","current":-16.016943,"twenty":-19.574255,"median":-12.922693,"eighty":-5.068498,"marketCap":526717158},{"date":"2021-04-09","current":-15.711664,"twenty":-19.474349,"median":-12.921607,"eighty":-5.067288,"marketCap":516678076},{"date":"2021-04-16","current":-15.284274,"twenty":-19.423718,"median":-12.921607,"eighty":-5.067288,"marketCap":502623362},{"date":"2021-04-23","current":-18.642337,"twenty":-19.348547,"median":-12.921607,"eighty":-5.067288,"marketCap":613053261},{"date":"2021-04-30","current":-18.502039,"twenty":-19.318728,"median":-12.921607,"eighty":-5.067288,"marketCap":608439564},{"date":"2021-05-07","current":-9.165707,"twenty":-19.246205,"median":-12.845506,"eighty":-5.067288,"marketCap":555845161},{"date":"2021-05-14","current":-8.747623,"twenty":-19.199134,"median":-12.654171,"eighty":-5.067288,"marketCap":530490820},{"date":"2021-05-21","current":-9.015626,"twenty":-19.199134,"median":-12.54111,"eighty":-5.067288,"marketCap":546743603},{"date":"2021-05-28","current":-7.67561,"twenty":-19.19054,"median":-12.410655,"eighty":-5.067288,"marketCap":465479690},{"date":"2021-06-04","current":-7.257525,"twenty":-19.109305,"median":-12.334551,"eighty":-5.067288,"marketCap":440125350},{"date":"2021-06-11","current":-7.67561,"twenty":-19.109305,"median":-12.217538,"eighty":-5.067288,"marketCap":465479690},{"date":"2021-06-18","current":-7.69705,"twenty":-19.109305,"median":-12.148707,"eighty":-5.067288,"marketCap":466779913},{"date":"2021-06-25","current":-6.914481,"twenty":-19.109305,"median":-12.059624,"eighty":-5.067288,"marketCap":419321788},{"date":"2021-07-02","current":-6.689358,"twenty":-19.101131,"median":-12.035228,"eighty":-5.067288,"marketCap":405669451},{"date":"2021-07-09","current":-6.507116,"twenty":-19.096054,"median":-12.010832,"eighty":-5.067288,"marketCap":394617559},{"date":"2021-07-16","current":-6.206953,"twenty":-19.021876,"median":-11.953909,"eighty":-5.067288,"marketCap":376414442},{"date":"2021-07-23","current":-5.94967,"twenty":-18.950858,"median":-11.888854,"eighty":-5.067288,"marketCap":360811771},{"date":"2021-07-30","current":-5.799588,"twenty":-18.890929,"median":-11.811434,"eighty":-5.067288,"marketCap":351710213},{"date":"2021-08-06","current":-5.327596,"twenty":-18.810436,"median":-11.750611,"eighty":-5.067288,"marketCap":342074265},{"date":"2021-08-13","current":-4.921684,"twenty":-18.643395,"median":-11.628633,"eighty":-5.057355,"marketCap":316011464},{"date":"2021-08-20","current":-4.728875,"twenty":-18.537367,"median":-11.542992,"eighty":-5.037769,"marketCap":303631633},{"date":"2021-08-27","current":-5.266709,"twenty":-18.470044,"median":-11.449731,"eighty":-5.033251,"marketCap":338164845},{"date":"2021-09-03","current":-5.21597,"twenty":-18.282192,"median":-11.400939,"eighty":-5.033251,"marketCap":334906995},{"date":"2021-09-10","current":-5.195674,"twenty":-18.214367,"median":-11.287092,"eighty":-5.033251,"marketCap":333603855},{"date":"2021-09-17","current":-5.3073,"twenty":-18.011705,"median":-11.171304,"eighty":-5.033251,"marketCap":340771125},{"date":"2021-09-24","current":-5.337744,"twenty":-17.880773,"median":-11.075663,"eighty":-5.033251,"marketCap":342725835},{"date":"2021-10-01","current":-5.185526,"twenty":-17.786094,"median":-11.006109,"eighty":-5.029108,"marketCap":332952285},{"date":"2021-10-08","current":-4.901388,"twenty":-17.593674,"median":-10.888629,"eighty":-5.022352,"marketCap":314708324},{"date":"2021-10-15","current":-5.21597,"twenty":-17.347957,"median":-10.734122,"eighty":-5.022352,"marketCap":334906995},{"date":"2021-10-22","current":-5.418926,"twenty":-17.286901,"median":-10.255278,"eighty":-5.022352,"marketCap":347938396},{"date":"2021-10-29","current":-6.017646,"twenty":-17.190067,"median":-10.091754,"eighty":-5.022352,"marketCap":386381027},{"date":"2021-11-05","current":-5.974365,"twenty":-17.127695,"median":-9.91655,"eighty":-5.022352,"marketCap":430644165},{"date":"2021-11-12","current":-6.354552,"twenty":-17.127695,"median":-9.702195,"eighty":-5.022352,"marketCap":458048794},{"date":"2021-11-19","current":-6.644218,"twenty":-17.127695,"median":-9.581303,"eighty":-5.022352,"marketCap":478928511},{"date":"2021-11-26","current":-6.110146,"twenty":-17.127695,"median":-9.533121,"eighty":-5.022352,"marketCap":440431533},{"date":"2021-12-03","current":-5.983417,"twenty":-17.127695,"median":-9.402102,"eighty":-5.022352,"marketCap":431296656},{"date":"2021-12-10","current":-5.693751,"twenty":-17.127695,"median":-9.370943,"eighty":-5.022352,"marketCap":410416939},{"date":"2021-12-17","current":-5.784271,"twenty":-17.127695,"median":-9.309923,"eighty":-5.022352,"marketCap":416941851},{"date":"2021-12-23","current":-3.819973,"twenty":-17.127695,"median":-9.214034,"eighty":-5.015418,"marketCap":275351269},{"date":"2021-12-31","current":-3.919545,"twenty":-17.127695,"median":-9.097316,"eighty":-4.989045,"marketCap":282528672},{"date":"2022-01-07","current":-3.521254,"twenty":-17.119715,"median":-9.010266,"eighty":-4.966268,"marketCap":253819061},{"date":"2022-01-14","current":-3.575567,"twenty":-17.119715,"median":-8.988637,"eighty":-4.961982,"marketCap":257734008},{"date":"2022-01-21","current":-3.883337,"twenty":-17.119715,"median":-8.85398,"eighty":-4.955638,"marketCap":279918707},{"date":"2022-01-28","current":-3.98291,"twenty":-17.119715,"median":-8.805781,"eighty":-4.940695,"marketCap":287096110},{"date":"2022-02-04","current":-3.856181,"twenty":-17.119715,"median":-8.758021,"eighty":-4.932273,"marketCap":277961234},{"date":"2022-02-11","current":-3.946702,"twenty":-17.119715,"median":-8.737148,"eighty":-4.904186,"marketCap":284486145},{"date":"2022-02-18","current":-3.711348,"twenty":-17.119715,"median":-8.689552,"eighty":-4.87848,"marketCap":267521375},{"date":"2022-02-25","current":-3.647983,"twenty":-17.119715,"median":-8.61807,"eighty":-4.874319,"marketCap":262953937},{"date":"2022-03-04","current":-2.093787,"twenty":-17.061962,"median":-8.407346,"eighty":-4.837766,"marketCap":242607132},{"date":"2022-03-11","current":-2.009133,"twenty":-17.009918,"median":-7.958591,"eighty":-4.791418,"marketCap":232798218},{"date":"2022-03-18","current":-1.811606,"twenty":-16.798456,"median":-7.750651,"eighty":-4.667881,"marketCap":209910753},{"date":"2022-03-25","current":-1.518137,"twenty":-16.708907,"median":-7.65953,"eighty":-4.531833,"marketCap":175906519},{"date":"2022-04-01","current":-1.58586,"twenty":-16.607213,"median":-7.518984,"eighty":-4.457209,"marketCap":183753649},{"date":"2022-04-08","current":-1.50685,"twenty":-16.57374,"median":-7.379808,"eighty":-4.397775,"marketCap":174598663},{"date":"2022-04-14","current":-1.303679,"twenty":-16.518509,"median":-7.230724,"eighty":-4.340581,"marketCap":151057270},{"date":"2022-04-22","current":-1.123083,"twenty":-16.311892,"median":-6.946642,"eighty":-4.261865,"marketCap":130131588},{"date":"2022-04-29","current":-0.965144,"twenty":-16.164988,"median":-6.796842,"eighty":-4.239985,"marketCap":111831187},{"date":"2022-05-06","current":-1.152331,"twenty":-16.037314,"median":-6.714191,"eighty":-4.169443,"marketCap":105945335},{"date":"2022-05-13","current":-1.251915,"twenty":-16.037314,"median":-6.648271,"eighty":-4.143215,"marketCap":115101104},{"date":"2022-05-20","current":-1.152331,"twenty":-16.037314,"median":-6.604751,"eighty":-4.08252,"marketCap":105945335},{"date":"2022-05-27","current":-1.152331,"twenty":-16.037314,"median":-6.566259,"eighty":-4.057616,"marketCap":105945335},{"date":"2022-06-03","current":-1.266142,"twenty":-16.037314,"median":-6.522189,"eighty":-4.032826,"marketCap":116409071},{"date":"2022-06-10","current":-1.323047,"twenty":-16.037314,"median":-6.480379,"eighty":-3.97927,"marketCap":121640940},{"date":"2022-06-17","current":-1.138105,"twenty":-16.037314,"median":-6.433323,"eighty":-3.95309,"marketCap":104637368},{"date":"2022-06-24","current":-1.3515,"twenty":-16.046011,"median":-6.408864,"eighty":-3.934785,"marketCap":124256874},{"date":"2022-07-01","current":-1.308821,"twenty":-16.046011,"median":-6.389195,"eighty":-3.9179,"marketCap":120332973},{"date":"2022-07-08","current":-0.92471,"twenty":-16.046011,"median":-6.376968,"eighty":-3.872475,"marketCap":85017861},{"date":"2022-07-15","current":-1.066973,"twenty":-16.046011,"median":-6.346314,"eighty":-3.809467,"marketCap":98097532},{"date":"2022-07-22","current":-1.031408,"twenty":-16.046011,"median":-6.316646,"eighty":-3.762177,"marketCap":94827614},{"date":"2022-07-29","current":-1.017181,"twenty":-16.046011,"median":-6.308028,"eighty":-3.738504,"marketCap":93519647},{"date":"2022-08-05","current":-1.130019,"twenty":-16.046011,"median":-6.26494,"eighty":-3.711348,"marketCap":109477401},{"date":"2022-08-12","current":-1.136827,"twenty":-16.046011,"median":-6.196,"eighty":-3.671605,"marketCap":110136904},{"date":"2022-08-19","current":-1.130019,"twenty":-16.046011,"median":-6.156937,"eighty":-3.629765,"marketCap":109477401},{"date":"2022-08-26","current":-1.041524,"twenty":-16.046011,"median":-6.121192,"eighty":-3.611561,"marketCap":100903870},{"date":"2022-09-02","current":-0.993872,"twenty":-16.046011,"median":-6.09259,"eighty":-3.569146,"marketCap":96287353},{"date":"2022-09-09","current":-1.089175,"twenty":-16.046011,"median":-6.049502,"eighty":-3.532316,"marketCap":105520387},{"date":"2022-09-16","current":-1.075561,"twenty":-16.046011,"median":-6.027794,"eighty":-3.511462,"marketCap":104201382},{"date":"2022-09-23","current":-0.97345,"twenty":-16.046011,"median":-5.997351,"eighty":-3.486665,"marketCap":94308846},{"date":"2022-09-30","current":-0.987065,"twenty":-16.046011,"median":-5.96096,"eighty":-3.449721,"marketCap":95627850},{"date":"2022-10-07","current":-0.953028,"twenty":-16.046011,"median":-5.928297,"eighty":-3.414806,"marketCap":92330338},{"date":"2022-10-14","current":-0.966643,"twenty":-16.046011,"median":-5.890191,"eighty":-3.396433,"marketCap":93649343},{"date":"2022-10-21","current":-0.905377,"twenty":-16.046011,"median":-5.862972,"eighty":-3.379973,"marketCap":87713821},{"date":"2022-10-28","current":-0.918992,"twenty":-16.046011,"median":-5.831748,"eighty":-3.331334,"marketCap":89032826},{"date":"2022-11-04","current":-0.850918,"twenty":-16.046011,"median":-5.784271,"eighty":-3.323074,"marketCap":82437802},{"date":"2022-11-11","current":-0.873514,"twenty":-16.046011,"median":-5.732321,"eighty":-3.273141,"marketCap":85248833},{"date":"2022-11-18","current":-1.178228,"twenty":-16.046011,"median":-5.677883,"eighty":-3.251622,"marketCap":114986798},{"date":"2022-11-25","current":-1.225628,"twenty":-16.046011,"median":-5.650664,"eighty":-3.224416,"marketCap":119612704},{"date":"2022-12-02","current":-1.157914,"twenty":-16.046011,"median":-5.620336,"eighty":-3.195939,"marketCap":113004267},{"date":"2022-12-09","current":-1.049571,"twenty":-16.046011,"median":-5.607113,"eighty":-3.110828,"marketCap":102430768},{"date":"2022-12-16","current":-1.063114,"twenty":-16.046011,"median":-5.569007,"eighty":-2.986764,"marketCap":103752456},{"date":"2022-12-23","current":-1.049571,"twenty":-16.046011,"median":-5.5407,"eighty":-2.919362,"marketCap":102430768},{"date":"2022-12-30","current":-1.083428,"twenty":-16.046011,"median":-5.520013,"eighty":-2.905032,"marketCap":105734987},{"date":"2023-01-06","current":-1.706399,"twenty":-16.021613,"median":-5.479813,"eighty":-2.876488,"marketCap":166532604},{"date":"2023-01-13","current":-1.936628,"twenty":-15.815007,"median":-5.458069,"eighty":-2.826882,"marketCap":189001289},{"date":"2023-01-20","current":-1.706399,"twenty":-15.672234,"median":-5.418926,"eighty":-2.80972,"marketCap":166532604},{"date":"2023-01-27","current":-1.875685,"twenty":-15.467441,"median":-5.400249,"eighty":-2.756449,"marketCap":183053696},{"date":"2023-02-03","current":-1.794428,"twenty":-15.286312,"median":-5.341948,"eighty":-2.654972,"marketCap":175123572},{"date":"2023-02-10","current":-1.719942,"twenty":-14.767548,"median":-5.325305,"eighty":-2.465003,"marketCap":167854292},{"date":"2023-02-17","current":-1.598056,"twenty":-14.638832,"median":-5.295802,"eighty":-2.294544,"marketCap":155959106},{"date":"2023-02-24","current":-1.442313,"twenty":-14.517074,"median":-5.28105,"eighty":-2.219541,"marketCap":140759701},{"date":"2023-03-03","current":-1.449085,"twenty":-14.054392,"median":-5.266709,"eighty":-2.138936,"marketCap":141420545},{"date":"2023-03-10","current":-1.259485,"twenty":-13.803918,"median":-5.257251,"eighty":-2.004618,"marketCap":122916922},{"date":"2023-03-17","current":-1.259485,"twenty":-13.049016,"median":-5.222044,"eighty":-1.906833,"marketCap":122916922},{"date":"2023-03-24","current":-1.151142,"twenty":-12.765494,"median":-5.214668,"eighty":-1.859433,"marketCap":112343423},{"date":"2023-03-31","current":-1.006921,"twenty":-12.62808,"median":-5.195674,"eighty":-1.814742,"marketCap":100004349},{"date":"2023-04-06","current":-0.993584,"twenty":-12.403697,"median":-5.18509,"eighty":-1.790365,"marketCap":98679788},{"date":"2023-04-14","current":-1.153624,"twenty":-12.106258,"median":-5.17779,"eighty":-1.734306,"marketCap":114574519},{"date":"2023-04-21","current":-1.086941,"twenty":-11.986239,"median":-5.165231,"eighty":-1.693089,"marketCap":107951714},{"date":"2023-04-28","current":-1.062043,"twenty":-11.596613,"median":-5.154405,"eighty":-1.669474,"marketCap":105478911},{"date":"2023-05-05","current":-1.115479,"twenty":-11.092,"median":-5.126159,"eighty":-1.604589,"marketCap":110786026},{"date":"2023-05-12","current":-1.662065,"twenty":-10.241261,"median":-5.114492,"eighty":-1.592633,"marketCap":117419920},{"date":"2023-05-18","current":-1.662065,"twenty":-10.005621,"median":-5.08928,"eighty":-1.592633,"marketCap":117419920},{"date":"2023-05-26","current":-1.605724,"twenty":-9.707425,"median":-5.066683,"eighty":-1.590375,"marketCap":113439583},{"date":"2023-06-02","current":-1.577553,"twenty":-9.509003,"median":-5.05675,"eighty":-1.577553,"marketCap":111449415},{"date":"2023-06-07","current":-1.586944,"twenty":-9.43545,"median":-5.053605,"eighty":-1.577553,"marketCap":112112805},{"date":"2023-06-16","current":-1.464871,"twenty":-9.370943,"median":-5.035235,"eighty":-1.563286,"marketCap":103488743},{"date":"2023-06-23","current":-1.42731,"twenty":-9.282028,"median":-5.023162,"eighty":-1.535759,"marketCap":100835185},{"date":"2023-06-30","current":-1.324018,"twenty":-9.164912,"median":-5.015391,"eighty":-1.507486,"marketCap":93537902},{"date":"2023-07-07","current":-1.699626,"twenty":-9.072816,"median":-4.992228,"eighty":-1.507486,"marketCap":120073477},{"date":"2023-07-14","current":-1.699626,"twenty":-8.996105,"median":-4.978644,"eighty":-1.50685,"marketCap":120073477},{"date":"2023-07-21","current":-1.680846,"twenty":-8.922199,"median":-4.962275,"eighty":-1.50685,"marketCap":118746699},{"date":"2023-07-28","current":-1.605724,"twenty":-8.822663,"median":-4.956516,"eighty":-1.50685,"marketCap":113439583},{"date":"2023-08-04","current":-1.577553,"twenty":-8.779783,"median":-4.941765,"eighty":-1.50685,"marketCap":111449415},{"date":"2023-08-11","current":-2.38569,"twenty":-8.747969,"median":-4.933588,"eighty":-1.50685,"marketCap":113439583},{"date":"2023-08-18","current":-2.35532,"twenty":-8.735869,"median":-4.904886,"eighty":-1.50685,"marketCap":99483990},{"date":"2023-08-25","current":-2.339512,"twenty":-8.649934,"median":-4.879071,"eighty":-1.50685,"marketCap":98816312},{"date":"2023-09-01","current":-2.371127,"twenty":-8.539552,"median":-4.870065,"eighty":-1.50685,"marketCap":100151668},{"date":"2023-09-08","current":-2.181437,"twenty":-8.281298,"median":-4.838504,"eighty":-1.50685,"marketCap":92139535},{"date":"2023-09-15","current":-2.181437,"twenty":-7.808558,"median":-4.797468,"eighty":-1.50685,"marketCap":92139535},{"date":"2023-09-22","current":-2.118207,"twenty":-7.690618,"median":-4.694622,"eighty":-1.50685,"marketCap":89468823},{"date":"2023-09-29","current":-2.023362,"twenty":-7.570553,"median":-4.543378,"eighty":-1.50685,"marketCap":85462757},{"date":"2023-10-06","current":-1.944324,"twenty":-7.460249,"median":-4.47683,"eighty":-1.50685,"marketCap":82124368},{"date":"2023-10-13","current":-1.896902,"twenty":-7.296875,"median":-4.400739,"eighty":-1.50685,"marketCap":80121334},{"date":"2023-10-20","current":-2.118207,"twenty":-7.080972,"median":-4.345558,"eighty":-1.50685,"marketCap":89468823},{"date":"2023-10-27","current":-1.786249,"twenty":-6.897329,"median":-4.267384,"eighty":-1.50685,"marketCap":75447590},{"date":"2023-11-03","current":-1.849479,"twenty":-6.768204,"median":-4.253588,"eighty":-1.50685,"marketCap":78118301},{"date":"2023-11-10","current":-5.023281,"twenty":-6.674971,"median":-4.240889,"eighty":-1.50685,"marketCap":80121334},{"date":"2023-11-17","current":-8.487937,"twenty":-6.669198,"median":-4.240889,"eighty":-1.50685,"marketCap":86415686},{"date":"2023-11-24","current":-8.948523,"twenty":-6.669198,"median":-4.240889,"eighty":-1.50685,"marketCap":91104909},{"date":"2023-12-01","current":-9.145917,"twenty":-6.669198,"median":-4.240889,"eighty":-1.50685,"marketCap":93114576},{"date":"2023-12-08","current":-9.606502,"twenty":-6.671374,"median":-4.24264,"eighty":-1.50685,"marketCap":97803799},{"date":"2023-12-15","current":-9.6723,"twenty":-6.669198,"median":-4.240889,"eighty":-1.50685,"marketCap":98473688},{"date":"2023-12-22","current":-9.277512,"twenty":-6.669198,"median":-4.240889,"eighty":-1.50685,"marketCap":94454354},{"date":"2023-12-29","current":-10.165785,"twenty":-6.658855,"median":-4.238628,"eighty":-1.50685,"marketCap":103497856},{"date":"2024-01-05","current":-10.198684,"twenty":-6.649081,"median":-4.236368,"eighty":-1.50685,"marketCap":103832801},{"date":"2024-01-12","current":-11.119855,"twenty":-6.649081,"median":-4.236368,"eighty":-1.50685,"marketCap":113211247},{"date":"2024-01-19","current":-11.054057,"twenty":-6.64075,"median":-4.231182,"eighty":-1.50685,"marketCap":112541358},{"date":"2024-01-26","current":-10.067088,"twenty":-6.649081,"median":-4.236368,"eighty":-1.50685,"marketCap":102493023},{"date":"2024-02-02","current":-10.067088,"twenty":-6.649081,"median":-4.236368,"eighty":-1.50685,"marketCap":102493023},{"date":"2024-02-09","current":-9.606502,"twenty":-6.649081,"median":-4.236368,"eighty":-1.50685,"marketCap":97803799},{"date":"2024-02-16","current":-9.869694,"twenty":-6.649081,"median":-4.236368,"eighty":-1.50685,"marketCap":100483356},{"date":"2024-02-23","current":-9.738098,"twenty":-6.649081,"median":-4.236368,"eighty":-1.50685,"marketCap":99143577},{"date":"2024-03-01","current":-16.1205,"twenty":-6.658855,"median":-4.238628,"eighty":-1.50685,"marketCap":164122814},{"date":"2024-03-08","current":-16.844278,"twenty":-6.658855,"median":-4.238628,"eighty":-1.50685,"marketCap":171491594},{"date":"2024-03-15","current":-245.178585,"twenty":-6.658855,"median":-4.238628,"eighty":-1.50685,"marketCap":139506615},{"date":"2024-03-22","current":-266.601956,"twenty":-6.658855,"median":-4.238628,"eighty":-1.50685,"marketCap":151696513},{"date":"2024-03-28","current":-260.689917,"twenty":-6.658855,"median":-4.238628,"eighty":-1.50685,"marketCap":148332563},{"date":"2024-04-05","current":-245.215172,"twenty":-6.649081,"median":-4.236368,"eighty":-1.50685,"marketCap":139527433},{"date":"2024-04-12","current":-255.928457,"twenty":-6.649081,"median":-4.236368,"eighty":-1.50685,"marketCap":145623292},{"date":"2024-04-19","current":-205.93313,"twenty":-6.649081,"median":-4.236368,"eighty":-1.50685,"marketCap":117175951},{"date":"2024-04-26","current":-190.458387,"twenty":-6.658855,"median":-4.238628,"eighty":-1.50685,"marketCap":108370822},{"date":"2024-05-03","current":-535.664214,"twenty":-6.658855,"median":-4.238628,"eighty":-1.50685,"marketCap":304792938},{"date":"2024-05-10","current":8.357394,"twenty":-6.64746,"median":-4.217605,"eighty":-1.472316,"marketCap":138172798},{"date":"2024-05-17","current":8.193524,"twenty":-6.64746,"median":-4.155757,"eighty":-1.455856,"marketCap":135463528},{"date":"2024-05-24","current":8.624717,"twenty":-6.64746,"median":-4.086161,"eighty":-1.44458,"marketCap":142592445},{"date":"2024-05-31","current":8.24768,"twenty":-6.64746,"median":-4.078366,"eighty":-1.425186,"marketCap":136358895},{"date":"2024-06-07","current":7.870643,"twenty":-6.64746,"median":-4.044422,"eighty":-1.381595,"marketCap":130125346},{"date":"2024-06-14","current":6.880922,"twenty":-6.649081,"median":-4.02817,"eighty":-1.363555,"marketCap":113762278},{"date":"2024-06-21","current":6.032589,"twenty":-6.650702,"median":-3.970254,"eighty":-1.332765,"marketCap":99736792},{"date":"2024-06-28","current":5.93833,"twenty":-6.658855,"median":-3.954687,"eighty":-1.325927,"marketCap":98178404},{"date":"2024-07-05","current":6.126848,"twenty":-6.658855,"median":-3.93891,"eighty":-1.323047,"marketCap":101295179},{"date":"2024-07-12","current":6.598144,"twenty":-6.653992,"median":-3.9179,"eighty":-1.302891,"marketCap":109087116},{"date":"2024-07-15","current":6.692403,"twenty":-6.653992,"median":-3.9179,"eighty":-1.298362,"marketCap":110645503},{"date":"2024-08-02","current":6.315366,"twenty":-6.689358,"median":-3.816355,"eighty":-1.266142,"marketCap":104411954},{"date":"2024-08-09","current":8.314881,"twenty":-6.689358,"median":-3.774712,"eighty":-1.247243,"marketCap":92178769},{"date":"2024-08-16","current":8.385346,"twenty":-6.689358,"median":-3.738504,"eighty":-1.230576,"marketCap":92959945},{"date":"2024-08-23","current":8.385346,"twenty":-6.689358,"median":-3.711348,"eighty":-1.212085,"marketCap":92959945},{"date":"2024-08-30","current":8.103486,"twenty":-6.689358,"median":-3.684192,"eighty":-1.202123,"marketCap":89835241},{"date":"2024-09-06","current":8.314881,"twenty":-6.689358,"median":-3.65026,"eighty":-1.178228,"marketCap":92178769},{"date":"2024-09-13","current":8.808136,"twenty":-6.689358,"median":-3.616096,"eighty":-1.164056,"marketCap":97647001},{"date":"2024-09-20","current":8.244416,"twenty":-6.689358,"median":-3.581932,"eighty":-1.153624,"marketCap":91397593},{"date":"2024-09-27","current":8.455811,"twenty":-6.689358,"median":-3.549144,"eighty":-1.151142,"marketCap":93741121},{"date":"2024-10-04","current":7.962555,"twenty":-6.689358,"median":-3.547642,"eighty":-1.145218,"marketCap":88272889},{"date":"2024-10-11","current":7.89209,"twenty":-6.689358,"median":-3.547642,"eighty":-1.138105,"marketCap":87491713},{"date":"2024-10-18","current":8.173951,"twenty":-6.689358,"median":-3.547642,"eighty":-1.133619,"marketCap":90616417},{"date":"2024-10-25","current":7.61023,"twenty":-6.689358,"median":-3.547642,"eighty":-1.123879,"marketCap":84367009},{"date":"2024-10-31","current":6.990137,"twenty":-6.689358,"median":-3.547642,"eighty":-1.123212,"marketCap":77492660},{"date":"2024-11-08","current":5.648417,"twenty":-6.689382,"median":-3.557463,"eighty":-1.116693,"marketCap":78117601},{"date":"2024-11-15","current":5.658632,"twenty":-6.689382,"median":-3.557463,"eighty":-1.109597,"marketCap":78258879},{"date":"2024-11-22","current":4.903204,"twenty":-6.689382,"median":-3.557463,"eighty":-1.103501,"marketCap":67811318},{"date":"2024-11-29","current":5.99815,"twenty":-6.689382,"median":-3.557463,"eighty":-1.100278,"marketCap":82954411},{"date":"2024-12-06","current":6.564013,"twenty":-6.689382,"median":-3.557463,"eighty":-1.089994,"marketCap":90780299},{"date":"2024-12-13","current":6.337668,"twenty":-6.689382,"median":-3.557463,"eighty":-1.088313,"marketCap":87649944},{"date":"2024-12-20","current":6.224495,"twenty":-6.689382,"median":-3.524056,"eighty":-1.083428,"marketCap":86084766},{"date":"2024-12-27","current":6.394254,"twenty":-6.689382,"median":-3.50315,"eighty":-1.075266,"marketCap":88432533},{"date":"2025-01-03","current":5.99815,"twenty":-6.689382,"median":-3.466942,"eighty":-1.066973,"marketCap":82954411},{"date":"2025-01-10","current":5.561303,"twenty":-6.689406,"median":-3.432284,"eighty":-1.062686,"marketCap":76912826},{"date":"2025-01-17","current":4.793427,"twenty":-6.689406,"median":-3.407046,"eighty":-1.052912,"marketCap":66293096},{"date":"2025-01-24","current":4.910561,"twenty":-6.689406,"median":-3.383641,"eighty":-1.045009,"marketCap":67913055},{"date":"2025-01-31","current":4.951303,"twenty":-6.689406,"median":-3.339237,"eighty":-1.04102,"marketCap":68476519},{"date":"2025-02-07","current":4.92301,"twenty":-6.689406,"median":-3.312429,"eighty":-1.030008,"marketCap":68085224},{"date":"2025-02-14","current":4.675727,"twenty":-6.689406,"median":-3.262613,"eighty":-1.023149,"marketCap":64665311},{"date":"2025-02-21","current":4.618009,"twenty":-6.689406,"median":-3.171091,"eighty":-1.017181,"marketCap":63867071},{"date":"2025-02-28","current":3.820708,"twenty":-6.689406,"median":-2.946017,"eighty":-1.014294,"marketCap":52840395},{"date":"2025-03-07","current":3.493073,"twenty":-6.68943,"median":-2.758827,"eighty":-1.008519,"marketCap":48309206},{"date":"2025-03-14","current":1.484923,"twenty":-6.68943,"median":-2.592432,"eighty":-0.997777,"marketCap":47323014},{"date":"2025-03-21","current":1.67368,"twenty":-6.68943,"median":-2.592432,"eighty":-0.993872,"marketCap":53338516},{"date":"2025-03-28","current":1.549769,"twenty":-6.68943,"median":-2.38569,"eighty":-0.983881,"marketCap":49389591},{"date":"2025-04-04","current":1.365033,"twenty":-6.68943,"median":-2.35532,"eighty":-0.968301,"marketCap":43502249},{"date":"2025-04-11","current":1.243133,"twenty":-6.689406,"median":-2.315801,"eighty":-0.959836,"marketCap":39617405},{"date":"2025-04-17","current":1.582695,"twenty":-6.689406,"median":-2.277053,"eighty":-0.953028,"marketCap":50438900},{"date":"2025-04-25","current":1.92477,"twenty":-6.68943,"median":-2.181437,"eighty":-0.913887,"marketCap":61340494},{"date":"2025-05-02","current":1.903406,"twenty":-6.68943,"median":-2.155867,"eighty":-0.89857,"marketCap":60659645},{"date":"2025-05-09","current":2.757451,"twenty":-6.660512,"median":-2.134014,"eighty":-0.878933,"marketCap":87877209},{"date":"2025-05-16","current":7.573702,"twenty":-6.623429,"median":-2.093787,"eighty":-0.851831,"marketCap":315088738},{"date":"2025-05-23","current":8.065993,"twenty":-6.623429,"median":-2.009133,"eighty":-0.824759,"marketCap":335569505},{"date":"2025-05-30","current":9.542865,"twenty":-6.623429,"median":-1.991747,"eighty":1.144607,"marketCap":397011809},{"date":"2025-06-06","current":9.088443,"twenty":-6.623429,"median":-1.975939,"eighty":1.42068,"marketCap":378106485}],"updateTime":1749439280901}}}